Trade CATX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Perspective Therapeutics, Inc. (CATX) is trading at US$2.98, up 3.30% today as of Sep 21, 12:41 EDT. The company has a market capitalisation of US$376.7M. Over the past 52 weeks, CATX has traded between US$1.96 and US$6.16. On Syfe you can trade CATX with $0 commission and add it to your watchlist.
| Previous close | US$2.88 |
|---|---|
| Market cap | US$376.7M |
| 52-week range | US$1.96 – US$6.16 |
| Volume | 11.64M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Year: 2003
BMO Capital Initiates Perspective Therapeutics at Outperform
Aug 19, 10:10 AM · MT Newswires
--BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6
Aug 14, 11:46 AM · MT Newswires
Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says
Aug 11, 3:39 PM · MT Newswires
Perspective Therapeutics, Inc. (CATX) stock is trading at US$2.98, +3.30% from the previous close of US$2.88.
The market cap for Perspective Therapeutics, Inc. (CATX) stock is approximately US$376.7M.
The 52-week high for Perspective Therapeutics, Inc. (CATX) stock is US$6.16.
The 52-week low for Perspective Therapeutics, Inc. (CATX) stock is US$1.96.
Perspective Therapeutics, Inc. (CATX) does not currently pay a dividend.
Stay on top of CATX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
